Duncker Streett & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.2M | Buy |
74,644
+2,632
| +4% | +$584K | 3.09% | 5 |
|
|
2025
Q4 | $16.5M | Buy |
72,012
+735
| +1% | +$167K | 2.92% | 7 |
|
|
2025
Q3 | $16.5M | Buy |
71,277
+10,721
| +18% | +$2.18M | 2.88% | 7 |
|
|
2025
Q2 | $11.2M | Buy |
60,556
+408
| +0.7% | +$75.8K | 2.05% | 12 |
|
|
2025
Q1 | $12.6M | Buy |
60,148
+15,559
| +35% | +$3.02M | 2.5% | 5 |
|
|
2024
Q4 | $7.92M | Sell |
44,589
-311
| -0.7% | -$57.2K | 1.47% | 14 |
|
|
2024
Q3 | $8.87M | Sell |
44,900
-14
| -0% | -$2.61K | 1.62% | 13 |
|
|
2024
Q2 | $7.7M | Buy |
44,914
+278
| +0.6% | +$46K | 1.48% | 14 |
|
|
2024
Q1 | $8.13M | Sell |
44,636
-983
| -2% | -$169K | 1.6% | 14 |
|
|
2023
Q4 | $7.07M | Sell |
45,619
-101
| -0.2% | -$14.7K | 1.49% | 15 |
|
|
2023
Q3 | $6.81M | Sell |
45,720
-72
| -0.2% | -$10.6K | 1.59% | 9 |
|
|
2023
Q2 | $6.17M | Sell |
45,792
-225
| -0.5% | -$33K | 1.38% | 14 |
|
|
2023
Q1 | $7.33M | Sell |
46,017
-972
| -2% | -$149K | 1.75% | 8 |
|
|
2022
Q4 | $7.59M | Sell |
46,989
-79
| -0.2% | -$12.1K | 1.83% | 6 |
|
|
2022
Q3 | $6.32M | Sell |
47,068
-27
| -0.1% | -$3.87K | 1.64% | 7 |
|
|
2022
Q2 | $7.21M | Sell |
47,095
-507
| -1% | -$77.5K | 1.73% | 7 |
|
|
2022
Q1 | $7.72M | Sell |
47,602
-4,872
| -9% | -$708K | 1.53% | 9 |
|
|
2021
Q4 | $7.11M | Buy |
52,474
+117
| +0.2% | +$13.8K | 1.22% | 15 |
|
|
2021
Q3 | $5.65M | Buy |
52,357
+1,451
| +3% | +$166K | 1.07% | 16 |
|
|
2021
Q2 | $5.73M | Buy |
50,906
+82
| +0.2% | +$9.23K | 1.06% | 16 |
|
|
2021
Q1 | $5.5M | Buy |
50,824
+301
| +0.6% | +$32.2K | 1.05% | 20 |
|
|
2020
Q4 | $5.41M | Buy |
50,523
+1,081
| +2% | +$104K | 1.05% | 21 |
|
|
2020
Q3 | $4.33M | Buy |
49,442
+88
| +0.2% | +$8.29K | 0.95% | 27 |
|
|
2020
Q2 | $4.85M | Sell |
49,354
-2,148
| -4% | -$189K | 1.15% | 16 |
|
|
2020
Q1 | $3.92M | Sell |
51,502
-297
| -0.6% | -$25.3K | 1.05% | 21 |
|
|
2019
Q4 | $4.59M | Sell |
51,799
-1,315
| -2% | -$109K | 0.96% | 23 |
|
|
2019
Q3 | $4.02M | Sell |
53,114
-6,117
| -10% | -$419K | 0.94% | 26 |
|
|
2019
Q2 | $4.31M | Sell |
59,231
-864
| -1% | -$67.9K | 0.97% | 18 |
|
|
2019
Q1 | $4.84M | Sell |
60,095
-4,328
| -7% | -$354K | 1.12% | 15 |
|
|
2018
Q4 | $5.94M | Sell |
64,423
-2,546
| -4% | -$224K | 1.59% | 7 |
|
|
2018
Q3 | $6.33M | Buy |
66,969
+19
| +0% | +$1.8K | 1.44% | 8 |
|
|
2018
Q2 | $6.2M | Sell |
66,950
-3,654
| -5% | -$357K | 1.54% | 7 |
|
|
2018
Q1 | $6.68M | Buy |
70,604
+6,414
| +10% | +$705K | 1.69% | 7 |
|
|
2017
Q4 | $6.21M | Buy |
64,190
+321
| +0.5% | +$30.3K | 1.6% | 6 |
|
|
2017
Q3 | $5.67M | Sell |
63,869
-1,194
| -2% | -$90.9K | 1.72% | 4 |
|
|
2017
Q2 | $4.72M | Sell |
65,063
-1,091
| -2% | -$73.3K | 1.47% | 6 |
|
|
2017
Q1 | $4.31M | Buy |
66,154
+3,022
| +5% | +$190K | 1.35% | 9 |
|
|
2016
Q4 | $3.95M | Buy |
63,132
+4,492
| +8% | +$274K | 1.31% | 8 |
|
|
2016
Q3 | $3.7M | Buy |
58,640
+1,455
| +3% | +$94.2K | 1.28% | 10 |
|
|
2016
Q2 | $3.54M | Buy |
57,185
+551
| +1% | +$33.6K | 1.26% | 11 |
|
|
2016
Q1 | $3.23M | Sell |
56,634
-435
| -0.8% | -$24.2K | 1.2% | 14 |
|
|
2015
Q4 | $3.38M | Buy |
57,069
+608
| +1% | +$35K | 1.27% | 12 |
|
|
2015
Q3 | $3.07M | Sell |
56,461
-1,583
| -3% | -$103K | 1.19% | 15 |
|
|
2015
Q2 | $3.9M | Buy |
58,044
+1,808
| +3% | +$118K | 1.36% | 8 |
|
|
2015
Q1 | $3.29M | Buy |
56,236
+768
| +1% | +$46.4K | 1.08% | 18 |
|
|
2014
Q4 | $3.63M | Buy |
55,468
+5
| +0% | +$315 | 1.19% | 12 |
|
|
2014
Q3 | $3.2M | Sell |
55,463
-1,942
| -3% | -$108K | 1.09% | 15 |
|
|
2014
Q2 | $3.24M | Buy |
57,405
+1,507
| +3% | +$79.1K | 1.05% | 16 |
|
|
2014
Q1 | $2.87M | Sell |
55,898
-1,053
| -2% | -$53.2K | 1.02% | 17 |
|
|
2013
Q4 | $3.01M | Buy |
56,951
+233
| +0.4% | +$11.5K | 1.08% | 15 |
|
|
2013
Q3 | $2.54M | Sell |
56,718
-1,478
| -3% | -$65.5K | 1.03% | 17 |
|
|
2013
Q2 | $2.41M | Buy |
+58,196
| New | +$2.55M | 0.92% | 20 |
|
Other funds holding ABBV
VCM
VPM
Duncker Streett & Co's ABBV Position: Q1 2026 in Review
Duncker Streett & Co increased its AbbVie (ABBV) stake by 3.7% in Q1 2026, buying an estimated $584K and bringing the position to 74,644 shares worth $16.2M. The position accounts for 3.09% of the portfolio, ranked #5.
Duncker Streett & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.5M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Duncker Streett & Co held 74,644 shares of AbbVie worth $16.2M as of Q1 2026.
- Duncker Streett & Co bought 2,632 AbbVie shares in Q1 2026, an estimated $584K.
- AbbVie made up 3.09% of Duncker Streett & Co's portfolio in Q1 2026, its #5 holding.
- Duncker Streett & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Duncker Streett & Co's AbbVie position peaked at $16.5M in Q3 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Duncker Streett & Co's 13F filing for Q1 2026, filed 29 Apr 2026.